Re-examining Permissive Hypercapnia in ARDS: A Narrative Review

Area of Science:

• Critical Care Medicine
• Pulmonary Medicine
• Physiology

Background:

• Lung-protective ventilation (LPV) is standard for Acute Respiratory Distress Syndrome (ARDS).
• Some ARDS patients cannot tolerate LPV, leading to permissive hypercapnia (elevated CO2).
• The physiological effects of permissive hypercapnia are increasingly recognized.

Purpose of the Study:

• To review the end-organ effects of elevated CO2 in ARDS patients.
• To explore the association between hypercapnia, acute cor pulmonale, and ICU mortality.
• To discuss alternative CO2 management strategies for ARDS.

Main Methods:

• Narrative review of animal models and clinical studies.
• Analysis of physiological effects of elevated CO2.
• Exploration of associations between CO2 levels and clinical outcomes.

Main Results:

• Elevated CO2 levels have significant, clinically relevant end-organ effects.
• A correlation exists between elevated CO2, acute cor pulmonale, and ICU mortality.
• Current literature highlights the detrimental impact of permissive hypercapnia.

Conclusions:

• Permissive hypercapnia in ARDS may have adverse effects beyond CO2 elevation.
• Further investigation into CO2 management is crucial for improving ARDS patient outcomes.
• Alternative therapies for CO2 control in ARDS require further study.